Longitudinal monitoring of EGFR mutations in plasma predicts outcomes of NSCLC patients treated with EGFR TKIs: Korean Lung Cancer Consortium (KLCC-12-02)

We hypothesized that plasma-based EGFR mutation analysis for NSCLC may be feasible for monitoring treatment response to EGFR TKIs and also predict drug resistance. Clinically relevant mutations including exon 19 deletion (ex19del), L858R and T790M were analyzed using droplet digital PCR (ddPCR) in l...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji Yun, Qing, Xu, Xiumin, Wei, Yali, Bai, Chi, Sangah, Bak, So Hyeon, Lee, Ho Yun, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Cho, Eun Kyung, Kim, Dong-Wan, Kim, Hye Ryun, Min, Young Joo, Jung, Sin-Ho, Park, Keunchil, Mao, Mao, Ahn, Myung-Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872763/
https://www.ncbi.nlm.nih.gov/pubmed/26755650
http://dx.doi.org/10.18632/oncotarget.6874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872763/
https://www.ncbi.nlm.nih.gov/pubmed/26755650
http://dx.doi.org/10.18632/oncotarget.6874

Ejemplares similares